A U.S. Perspective on Global Strategy
Worldwide Bolar Exemptions
Many countries have exemptions for patent infringement for a product and/or process that is not being used for direct commercialization and profit. For biopharmaceuticals, this exemption, commonly known as a “Bolar exemption”, permits activities with a commercial benefit as long as the activities are reasonably related to obtaining information relevant to a submission for regulatory approval. The December 2017 issue of Sterne Kessler’s Global Patent Prosecution Newsletter includes information on Bolar exemptions worldwide.
In this issue:
- Bolar Exemptions in North America
- Bolar Exemption in Europe and Asia
- Worldwide Bolar-type Provisions*
To read the full newsletter, please click the download button.